Literature DB >> 20890048

Primary percutaneous coronary intervention lowers the incidence of ischemic mitral regurgitation in patients with acute ST-elevated myocardial infarction.

Sarah Chua1, Judy Hung, Sheng-Ying Chung, Yu-Chun Lin, Morgan Fu, Chiung-Jen Wu, Chi-Ling Hang, Han-Tan Chai, Wen-Hao Liu, Cheng-Hsu Yang, Tzu-Hsien Tsai, Chien-Jen Chen, Hon Kan Yip.   

Abstract

BACKGROUND: The impact of primary percutaneous coronary intervention (PCI) for acute ST-elevated myocardial infarction (STEMI) on the incidence of ischemic mitral regurgitation (IMR) is unclear. METHODS AND
RESULTS: Between January 2000 and December 2004, 318 patients presenting with first acute STEMI were enrolled in this study. Two hundred and twelve (66.67%) patients received PCI (PCI group), and 106 age- and Killip class-matched patients received medical management (non-PCI group). The median duration of follow up was 40.46 months. Compared to the non-PCI group, the PCI group had 14.6% (9.9% vs 24.5%) fewer patients with moderate or severe IMR (P<0.001). Univariate analysis demonstrated IMR was significantly associated with advanced age, higher Killip score, and posterior myocardial infarction (MI). Moreover, IMR was strongly associated with a lower left ventricular (LV) ejection fraction, larger left atrial dimension (LAd), and a larger LV end-systolic and LV end-diastolic volumes (LVEDV) (all P<0.01). Multivariate analysis revealed the odds of IMR in the PCI group was 0.208 times those of the non-PCI group (P<0.001). Additionally, moderate or severe IMR was independently correlated with advanced age, inferior MI, Killip class ≥3, larger LAd, and larger LVEDV (all P<0.05). Furthermore, long-term survival time was longer in the PCI group without IMR than in the non-PCI group with IMR (all P<0.01).
CONCLUSIONS: PCI for first acute STEMI was associated with lower incidence of IMR. Advanced age, inferior MI, Killip class ≥3, larger LAd and LVEDV were risk factors associated with IMR development.

Entities:  

Mesh:

Year:  2010        PMID: 20890048     DOI: 10.1253/circj.cj-10-0435

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  6 in total

1.  Two-dimensional speckle-tracking echocardiography assessment of left ventricular remodeling in patients after myocardial infarction and primary reperfusion.

Authors:  Jerzy Liszka; Maciej Haberka; Zbigniew Tabor; Maciej Finik; Zbigniew Gąsior
Journal:  Arch Med Sci       Date:  2014-12-22       Impact factor: 3.318

2.  Percutaneous coronary intervention for acute myocardial infarction with mitral regurgitation.

Authors:  Yan Tu; Qing-Chun Zeng; Ying Huang; Jian-Yong Li
Journal:  J Geriatr Cardiol       Date:  2016-09       Impact factor: 3.327

3.  Outcomes of ischaemic mitral regurgitation in anterior versus inferior ST elevation myocardial infarction.

Authors:  Amgad Mentias; Mohammad Q Raza; Amr F Barakat; Elizabeth Hill; Dalia Youssef; Amar Krishnaswamy; Milind Y Desai; Brian Griffin; Stephen Ellis; Venu Menon; E Murat Tuzcu; Samir R Kapadia
Journal:  Open Heart       Date:  2016-11-10

4.  Trends in Ischemic Mitral Regurgitation Following ST-Elevation Myocardial Infarction Over a 20-Year Period.

Authors:  Leor Perl; Tamir Bental; Katia Orvin; Hana Vaknin-Assa; Gabriel Greenberg; Pablo Codner; Yaron Shapira; Mordehay Vaturi; Alexander Sagie; Ran Kornowski
Journal:  Front Cardiovasc Med       Date:  2022-01-13

Review 5.  Percutaneous mitral valve repair in patients developing severe mitral regurgitation early after an acute myocardial infarction: A review.

Authors:  Rodrigo Estévez-Loureiro; Marta Tavares Da Silva; José Antonio Baz-Alonso; Berenice Caneiro-Queija; Manuel Barreiro-Pérez; Francisco Calvo-Iglesias; Rocio González-Ferreiro; Luis Puga; Miguel Piñón; Andrés Íñiguez-Romo
Journal:  Front Cardiovasc Med       Date:  2022-09-23

6.  Predictors and prognosis of early ischemic mitral regurgitation in the era of primary percutaneous coronary revascularisation.

Authors:  Jimmy MacHaalany; Olivier F Bertrand; Kim O'Connor; Eltigani Abdelaal; Pierre Voisine; Éric Larose; Éric Charbonneau; Olivier Costerousse; Jean-Pierre Déry; Mario Sénéchal
Journal:  Cardiovasc Ultrasound       Date:  2014-04-03       Impact factor: 2.062

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.